Lack of an association between serum level of transforming growth factor beta -1 and stomach cancer risk in the JACC study.

Hiroshi Yatsuya, Akiko Tamakoshi, Koji Tamakoshi, Yoshiharu Hoshiyama, Yoshihisa Fujino, Noritaka Tokui, Tetsuya Mizoue, Shogo Kikuchi, Kiyomi Sakata, Norihiko Hayakawa, Takaaki Kondo, Hideaki Toyoshima, Takesumi Yoshimura

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Alterations in the serum concentration of transforming growth factor beta-1 (TGFbeta1) have been observed in gastric cancer patients. No study, however, has ever examined the association between the serum TGFbeta1 level and stomach cancer prospectively. We conducted a prospective, nested case-control analysis among apparently healthy men and women who were followed for up to 8 years in the JACC Study to assess whether serum level of total TGFbeta1 is associated with a subsequent risk of stomach cancer. The concentration of serum TGFbeta1 in previously collected blood samples was analyzed by ELISA for 209 individuals in whom a diagnosis of stomach cancer was documented, and for 409 controls matched with them for gender, age and study area. Baseline blood levels of TGFbeta1 were not related to the risk of stomach cancer in either men or women, a finding unchanged even after adjustment for potential confounders. The multivariate-adjusted odds ratio of stomach cancer in men and women was 1.10 (95% CI, 0.82 to 1.48) and 1.09 (95% CI, 0.80 to 1.48), respectively, for each increase of 1 SD in the TGFbeta1 value. In conclusion, serum TGFbeta1 levels were not associated with increased risks of subsequent stomach cancer.gene A52C polymorphism related to the metabolism of long-chain fatty acids and oxidized LDL in the etiology of colorectal cancer.

Original languageEnglish
Pages (from-to)170-176
Number of pages7
JournalAsian Pacific journal of cancer prevention : APJCP
Volume6
Issue number2
Publication statusPublished - 01-01-2005
Externally publishedYes

Fingerprint

Transforming Growth Factor beta
Stomach Neoplasms
Serum
Colorectal Neoplasms
Fatty Acids
Enzyme-Linked Immunosorbent Assay
Odds Ratio
Genes

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Yatsuya, Hiroshi ; Tamakoshi, Akiko ; Tamakoshi, Koji ; Hoshiyama, Yoshiharu ; Fujino, Yoshihisa ; Tokui, Noritaka ; Mizoue, Tetsuya ; Kikuchi, Shogo ; Sakata, Kiyomi ; Hayakawa, Norihiko ; Kondo, Takaaki ; Toyoshima, Hideaki ; Yoshimura, Takesumi. / Lack of an association between serum level of transforming growth factor beta -1 and stomach cancer risk in the JACC study. In: Asian Pacific journal of cancer prevention : APJCP. 2005 ; Vol. 6, No. 2. pp. 170-176.
@article{eee757253b294d17ba2e838053f57383,
title = "Lack of an association between serum level of transforming growth factor beta -1 and stomach cancer risk in the JACC study.",
abstract = "Alterations in the serum concentration of transforming growth factor beta-1 (TGFbeta1) have been observed in gastric cancer patients. No study, however, has ever examined the association between the serum TGFbeta1 level and stomach cancer prospectively. We conducted a prospective, nested case-control analysis among apparently healthy men and women who were followed for up to 8 years in the JACC Study to assess whether serum level of total TGFbeta1 is associated with a subsequent risk of stomach cancer. The concentration of serum TGFbeta1 in previously collected blood samples was analyzed by ELISA for 209 individuals in whom a diagnosis of stomach cancer was documented, and for 409 controls matched with them for gender, age and study area. Baseline blood levels of TGFbeta1 were not related to the risk of stomach cancer in either men or women, a finding unchanged even after adjustment for potential confounders. The multivariate-adjusted odds ratio of stomach cancer in men and women was 1.10 (95{\%} CI, 0.82 to 1.48) and 1.09 (95{\%} CI, 0.80 to 1.48), respectively, for each increase of 1 SD in the TGFbeta1 value. In conclusion, serum TGFbeta1 levels were not associated with increased risks of subsequent stomach cancer.gene A52C polymorphism related to the metabolism of long-chain fatty acids and oxidized LDL in the etiology of colorectal cancer.",
author = "Hiroshi Yatsuya and Akiko Tamakoshi and Koji Tamakoshi and Yoshiharu Hoshiyama and Yoshihisa Fujino and Noritaka Tokui and Tetsuya Mizoue and Shogo Kikuchi and Kiyomi Sakata and Norihiko Hayakawa and Takaaki Kondo and Hideaki Toyoshima and Takesumi Yoshimura",
year = "2005",
month = "1",
day = "1",
language = "English",
volume = "6",
pages = "170--176",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "2",

}

Yatsuya, H, Tamakoshi, A, Tamakoshi, K, Hoshiyama, Y, Fujino, Y, Tokui, N, Mizoue, T, Kikuchi, S, Sakata, K, Hayakawa, N, Kondo, T, Toyoshima, H & Yoshimura, T 2005, 'Lack of an association between serum level of transforming growth factor beta -1 and stomach cancer risk in the JACC study.', Asian Pacific journal of cancer prevention : APJCP, vol. 6, no. 2, pp. 170-176.

Lack of an association between serum level of transforming growth factor beta -1 and stomach cancer risk in the JACC study. / Yatsuya, Hiroshi; Tamakoshi, Akiko; Tamakoshi, Koji; Hoshiyama, Yoshiharu; Fujino, Yoshihisa; Tokui, Noritaka; Mizoue, Tetsuya; Kikuchi, Shogo; Sakata, Kiyomi; Hayakawa, Norihiko; Kondo, Takaaki; Toyoshima, Hideaki; Yoshimura, Takesumi.

In: Asian Pacific journal of cancer prevention : APJCP, Vol. 6, No. 2, 01.01.2005, p. 170-176.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Lack of an association between serum level of transforming growth factor beta -1 and stomach cancer risk in the JACC study.

AU - Yatsuya, Hiroshi

AU - Tamakoshi, Akiko

AU - Tamakoshi, Koji

AU - Hoshiyama, Yoshiharu

AU - Fujino, Yoshihisa

AU - Tokui, Noritaka

AU - Mizoue, Tetsuya

AU - Kikuchi, Shogo

AU - Sakata, Kiyomi

AU - Hayakawa, Norihiko

AU - Kondo, Takaaki

AU - Toyoshima, Hideaki

AU - Yoshimura, Takesumi

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Alterations in the serum concentration of transforming growth factor beta-1 (TGFbeta1) have been observed in gastric cancer patients. No study, however, has ever examined the association between the serum TGFbeta1 level and stomach cancer prospectively. We conducted a prospective, nested case-control analysis among apparently healthy men and women who were followed for up to 8 years in the JACC Study to assess whether serum level of total TGFbeta1 is associated with a subsequent risk of stomach cancer. The concentration of serum TGFbeta1 in previously collected blood samples was analyzed by ELISA for 209 individuals in whom a diagnosis of stomach cancer was documented, and for 409 controls matched with them for gender, age and study area. Baseline blood levels of TGFbeta1 were not related to the risk of stomach cancer in either men or women, a finding unchanged even after adjustment for potential confounders. The multivariate-adjusted odds ratio of stomach cancer in men and women was 1.10 (95% CI, 0.82 to 1.48) and 1.09 (95% CI, 0.80 to 1.48), respectively, for each increase of 1 SD in the TGFbeta1 value. In conclusion, serum TGFbeta1 levels were not associated with increased risks of subsequent stomach cancer.gene A52C polymorphism related to the metabolism of long-chain fatty acids and oxidized LDL in the etiology of colorectal cancer.

AB - Alterations in the serum concentration of transforming growth factor beta-1 (TGFbeta1) have been observed in gastric cancer patients. No study, however, has ever examined the association between the serum TGFbeta1 level and stomach cancer prospectively. We conducted a prospective, nested case-control analysis among apparently healthy men and women who were followed for up to 8 years in the JACC Study to assess whether serum level of total TGFbeta1 is associated with a subsequent risk of stomach cancer. The concentration of serum TGFbeta1 in previously collected blood samples was analyzed by ELISA for 209 individuals in whom a diagnosis of stomach cancer was documented, and for 409 controls matched with them for gender, age and study area. Baseline blood levels of TGFbeta1 were not related to the risk of stomach cancer in either men or women, a finding unchanged even after adjustment for potential confounders. The multivariate-adjusted odds ratio of stomach cancer in men and women was 1.10 (95% CI, 0.82 to 1.48) and 1.09 (95% CI, 0.80 to 1.48), respectively, for each increase of 1 SD in the TGFbeta1 value. In conclusion, serum TGFbeta1 levels were not associated with increased risks of subsequent stomach cancer.gene A52C polymorphism related to the metabolism of long-chain fatty acids and oxidized LDL in the etiology of colorectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=24944465767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944465767&partnerID=8YFLogxK

M3 - Article

C2 - 16101328

AN - SCOPUS:24944465767

VL - 6

SP - 170

EP - 176

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 2

ER -